Article

Linear DNA low efficiency transfection by liposome can be improved by the use of cationic lipid as charge neutralizer.

Departamento de Patologia Clínica Veterinaria, Faculdade de Veterinaria, and Departamento de Física Teórica, Instituto de Física, Universidade Federal do Rio Grande do Sul, Campus do Vale, Porto Alegre, RS, Brazil.
Biotechnology Progress (impact factor: 2.34). 22(4):1220-4. DOI:10.1021/bp060029s pp.1220-4
Source: PubMed

ABSTRACT A plasmid expressing the beta-galactosidase enzyme was used to transfect Vero cells in order to evaluate the efficiency of a liposome-mediated transfection by circular and linear DNA. The results obtained showed a low rate of transfection by linear DNA:liposome complexes. To explore whether the structure of the complexes was interfering with the transfection, atomic force microscopy (AFM) was used. It has confirmed the difference between the linear and circular condensates: whereas the circular DNA:liposome complexes presented compact spherical or cylindrical structures of about 100-800 nm, the linear DNA showed pearl necklace-like structures, with pearls varying from 250 to 400 nm. On the basis of the theory proposed by Kuhn et al. (1999), low concentrations of cationic amphihile were used to neutralize or reverse the DNA charge in order to improve the transfection efficiency of the linear DNA. Using this method, we were able to obtain the expression of the transgene without an associated toxicity observed with the linear DNA liposome delivery.

0 0
 · 
0 Bookmarks
 · 
23 Views
  • Article: Partial correction of murine hereditary growth disorder by germ-line incorporation of a new gene.
    [show abstract] [hide abstract]
    ABSTRACT: The dwarf little (lit) mouse is a model for the human hereditary disorder, isolated growth hormone (GH) deficiency type I. In these animals, dwarfism results from an autosomal recessively inherited gene mutation. The GH gene is present but production of GH mRNA is deficient, resulting in reduced serum GH and concomitantly decreased serum somatomedin. Growth retardation is evident by 15 days of age and adult animals reach approximately one-half normal size. Mutant mice of both sexes also exhibit a delayed onset of puberty, with males having a high degree of infertility. As administration of GH restores growth, we reasoned that growth failure in the mutant mice might be corrected by providing them with sufficient GH by gene therapy. Here we demonstrate that although the rat and human GH genes alone do not restore growth in transgenic mutants, a metallothionein-rat growth hormone fusion gene (MT-rGH) does. Moreover, the fertility of transgenic mutant males is improved; however, female fertility is impaired.
    Nature 311(5981):65-7. · 36.28 Impact Factor
  • Article: Genetic immunization is a simple method for eliciting an immune response.
    [show abstract] [hide abstract]
    ABSTRACT: To produce an immune reaction against a foreign protein usually requires purification of that protein, which is then injected into an animal. The isolation of enough pure protein is time-consuming and sometimes difficult. Here we report that such a response can also be elicited by introducing the gene encoding a protein directly into the skin of mice. This is achieved using a hand-held form of the biolistic system which can propel DNA-coated gold microprojectiles directly into cells in the living animal. Genetic immunization may be time- and labour-saving in producing antibodies and may offer a unique method for vaccination.
    Nature 04/1992; 356(6365):152-4. · 36.28 Impact Factor
  • Article: Biological barriers to cellular delivery of lipid-based DNA carriers.
    [show abstract] [hide abstract]
    ABSTRACT: Although lipid-based DNA delivery systems are being assessed in gene therapy clinical trials, many investigators in this field are concerned about the inefficiency of lipid-based gene transfer technology, a criticism directed at all formulations used to enhance transfer of plasmid expression vectors. It is important to recognize that many approaches have been taken to improve transfection efficiency, however because of the complex nature of the formulation technology being developed, it has been extremely difficult to define specific carrier attributes that enhance transfection. We believe that these optimization processes are flawed for two reasons. First, a very defined change in formulation components affects the physical and chemical characteristics of the carrier in many ways. As a consequence, it has not been possible to define structure/activity relationships. Second, the primary endpoint used to assess plasmid delivery has been transgene expression, an activity that is under the control of cellular processes that have nothing to do with delivery. Gene expression following administration of a plasmid expression vector involves a number of critical steps: (i) DNA protection, (ii) binding to a specific cell population, (iii) DNA transfer across the cell membrane, (iv) release of DNA into the cytoplasm, (v) transport through the cell and across the nuclear membrane as well as (vi) transcription and translation of the gene. The objective of this review is to describe lipid-based DNA carrier systems and the attributes believed to be important in regulating the transfection activity of these formulations. Although membrane destabilization activity of the lipid-based carriers plays an important role, we suggest here that a critical element required for efficient transfection is dissociation of lipids bound to the plasmid expression vector following internalization.
    Advanced drug delivery reviews 09/1999; 38(3):291-315. · 11.96 Impact Factor

Full-text (2 Sources)

View
6 Downloads
Available from
5 Nov 2012

Keywords

associated toxicity
 
beta-galactosidase enzyme
 
cationic amphihile
 
circular
 
circular condensates
 
cylindrical structures
 
DNA charge
 
Kuhn
 
linear
 
linear DNA
 
linear DNA liposome delivery
 
liposome-mediated transfection
 
low concentrations
 
low rate
 
pearl necklace-like structures
 
transfect Vero cells
 
transfection
 
transfection efficiency
 
transgene